| Schedule of Computation of Basic and Diluted Net Loss Per Share |
The following table sets forth the computation of basic and diluted net loss per share of common stock, Series A Preferred Stock, and Series B Preferred Stock (in thousands, except share and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | 2026 | | 2025 | | | Series A Preferred Stock | | Series B Preferred Stock | | Common Stock | | Series A Preferred Stock | | Series B Preferred Stock | | Common Stock | | | Net loss per share, basic and diluted: | | | | | | | | | | | | | | Numerator | | | | | | | | | | | | | | Allocation of losses | $ | (5,052) | | | $ | (225) | | | $ | (30,923) | | | $ | (6,791) | | | $ | (327) | | | $ | (29,599) | | | | Denominator | | | | | | | | | | | | | | Weighted-average shares outstanding | 346,045 | | 15,385 | | 84,729,435 | | 346,045 | | | 16,667 | | | 60,333,838 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net loss per share, basic and diluted | $ | (14.60) | | | $ | (14.60) | | | $ | (0.36) | | | $ | (19.62) | | | $ | (19.62) | | | $ | (0.49) | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | | 2026 | | 2025 | | | Series A Preferred Stock | | Series B Preferred Stock | | Common Stock | | Series A Preferred Stock | | Series B Preferred Stock | | Common Stock | | | Net loss per share, basic and diluted: | | | | | | | | | | | | | | Numerator | | | | | | | | | | | | | | Allocation of losses | $ | (15,147) | | | $ | (701) | | | $ | (89,357) | | | $ | (15,078) | | | $ | (726) | | | $ | (65,686) | | | | Denominator | | | | | | | | | | | | | | Weighted-average shares outstanding | 346,045 | | 16,022 | | 81,656,119 | | 346,045 | | | 16,667 | | | 60,300,073 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net loss per share, basic and diluted | $ | (43.77) | | | $ | (43.77) | | | $ | (1.09) | | | $ | (43.57) | | | $ | (43.57) | | | $ | (1.09) | | |
|
| Schedule of Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share |
The following weighted-average equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Options to purchase common stock | 8,042,158 | | 805,306 | | 6,630,827 | | 1,324,645 | | Unvested restricted stock units | 137,358 | | — | | 113,115 | | 11,943 | | Outstanding Parapyre warrants | 1,532,591 | | — | | 1,532,591 | | — | | | | | | | | | | | | | | | | |
|